Human Papilloma Virus infection and cervical cancer in Romania
Keywords:
cervix cancer, Human papilloma virus, koilocyte.Abstract
Infection with human papillomaviruses (HPV) is a major public health burden worldwide and is associated with a variety of epithelial lesions, including benign warts and several types of anogenital tumors, particularly cervical carcinoma.HPV can be grouped into cutaneous types and mucosal types based on their preferred tissue tropism. Cutaneous types are typically found in the general population and cause common warts. Mucosal HPV is further classified into high-risk and low-risk types, based on their association with cervical cancer. The most common low-risk types are HPV 6 and 11, detected most often in benign genital warts. HPV 16, 18, 31, and 45 are predominant types found in cervical squamous cell carcinoma. HPV 16 is the most prevalent type in cervical cancer (55%), followed by HPV 18 and HPV 45. Epidemiological evidence has convincingly demonstrated that infection with HPV is the greatest risk factor, its role in the progression of the precursor lesions to cervical cancer is well established. HPV is exclusively epitheliotropic, and their replication is linked to the differentiation process of the host cells. Normal squamous epithelial cells grow as stratified epithelium, with those in the basal layers dividing as stem cells of transient amplifying cells. After division, one of the daughter cells migrates upward and begins to undergo terminal differentiation while the other remains in the basal layer as a slow-cycling, self-renewing population. Productive papillomavirus infection begins when infectious virions gain access to cells of the basal layer, probably through micro-wounds. The viral genome is maintained in these cells at low copy number. These infected cells from the reservoir for the development of a productive wart. Early HPV genes E1 and E2 support viral DNA replication and its segregation such that the infected cells can be maintained in the lesion for a long period. As infected daughter cells migrate towards the epithelial surface, viral late gene products are produced to initiate the vegetative phase of the HPV life cycle, resulting in the high-level amplification of the viral genome. In the outer layers of the epithelium viral DNA is packaged into capsids and progeny virions are released to reinitiate infection. Given the worldwide burden of HPV infection (anogenital warts and neoplasia of several sites), prevention of infection could provide relief from an important public health threat. With the introduction of cervical screening in developed countries, the number of deaths from cervical cancer has declined dramatically, but in developing countries it still remains the number one of female cancer.
References
Anic, G.M., Giuliano, A.R. (2012) Genital HPV infection and related lesions in men, Preventive Medicine, 53 (Supp 1), S36–S41
Chaturvedi, A.K, Myers, L., Hammons A.F. (2005) Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections, Cancer Epidemiol. Biomark. Prev., 14, 2439–45
Deng,T., Feng, Y., Zheng, J., Huang, Q., Liu, J. (2015) Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery, J. Gynecol. Oncol., 26(2), 111–117, doi: 10.3802/jgo.2015.26.2.111
Fotopoulos, G., Pavlidis, N. (2015) The role of human papilloma virus and p16 in occult primary of the head and neck: A comprehensive review of the literature, Oral Oncol.,51, 119-123
Ganguly, N., Parihar, S. P. (2009) Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis, J. Biosci., 34(1),113-23
Grm, H.S., Bergant, M., Banks, L. (2009) Human papillomavirus infection, cancer and therapy, Indian J. Med. Res., 130, 277-285
Gross, G. (2014) Genitoanal human papillomavirus infection and associated neoplasias, Curr. Probl. Dermatol., 45, 98-122, doi: 10.1159/000358423
Hamkar, R., Delforoush, M. (2009) A review of human papillomavirus and related vaccines, Iranian Journal of Gynecology Oncology, 2(2), 11-27
Hebner, C.M., Laimins, L.A. (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity, Rev. Med. Virol., 16, 83-97
Lin, Y.Y., Alphs, H., Hung, C.F., Roden, R.B., Wu, T.C. (2007) Vaccines against human papillomavirus, Front Biosci., 12, 246-64.
Moscicki, A.-B., Schiffman, M., Burchell, A., Albero, G., Giuliano, A., Marc, T., Goodman, M. T., Kjaer, S.K., Joel Palefsky, J. (2012) Updating the natural history of human papillomavirus and anogenital cancers, Vaccine, 30(5), F24–F33, doi: 10.1016/j.vaccine.2012.05.089
Muñoz, N., Bosch, F.X., Sanjosé, S., Herrero, R., Xavier C., Keerti V.S., Snijders, P., Meijer, C. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer, N. Engl. J. Med., 348, 518-527, doi:10.1056/NEJMoa021641
Muñoz, N., Kjaer, K.S., Sigurdsson, K., Iversen, O.E., Hernandez-Avila, M., Wheeler, C.M., Perez, G., Brown, D.R., Koutsky, L.A., Tay, E.H., Garcia, P.J., Ault, K.A., Garland, S.M., Leodolter, S., Olsson, S.E., Tang, G.W., Ferris, D.G., Paavonen, J., Steben, M., Bosch, F.X., Dillner, J., Huh, W.K., Joura, E.A., Kurman, R.J., Majewski, S., Myers, E.R., Villa, L.L., Taddeo, F.J., Roberts, C., Tadesse, A., Bryan, J.T., Lupinacci, L.C., Giacoletti, K.E., Sings, H.L., James, M.K., Hesley, T.M., Barr, E., Haupt, R.M. (2010) Impact of human papillomavirus (HPV)- 6/11/16/18 vaccine on all HPV-associated genital diseases in young women, JNCI, 102(5), 325-339
Prétet, J.L., Charlot, J.F., Mougin, C. (2007) Virological and carcinogenic aspects of HPV, Bull. Acad. Natl. Med., 191(3), 611-623
Saslow, D., Solomon, D., Lawson, H.W., Killackey, M., Kulasingam, S.L., Cain, J., Garcia, F., Moriarty, A.T., Waxman, A.G., Wilbur, D.C., Wentzensen, N., Downs, L.S., Spitzer, M., Moscicki, A.B., Franco, E.L., Stoler, M.H., Schiffman, M., Philip E., Castle, P.E., Myers, E.R. (2012) American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer, Am. J. Clin. Pathol., 137, 516-542
Smith, J.S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., Clifford, G.M. (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update, Int. J. Cancer, 121(3), 621-32
Stanley, M.A., Winder, D.M., Sterling, J.C., Goon, P.K. (2012) HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues, BMC Cancer 12(1), 398, doi:10.1186/1471-2407-12-398
Szentirmay, Z., Pólus, K., Tamás, L., Szentkuti, G., Kurcsics, J., Csernák, E. (2005) Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations, Cancer and metastasis reviews, 24(1), 19-34
Wright, T., Schiffman, M. (2003) Adding a test for human papillomavirus DNA to cervical-cancer screening, N. Engl. J. Med., 348, 489-490, doi: 10.1056/NEJMp020178
Zheng, Z.-M., Baker, C.C. (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation, Front Biosci., 11, 2286–2302
http://www.hpvcentre.net/statistics/reports/ROU.pdf, 2015
wikipedia.org/wiki/Human_papillomavirus
http://en.wikipedia.org/wiki/Wart
http://en.wikipedia.org/wiki/Genital_wart
http://commons.wikimedia.org/wiki/File:ThinPrep_Pap_smear_HPV.jpeg
http://www.nobelprize.org/nobel_prizes/medicine/laureates/2008/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 Studia Universitatis Babeș-Bolyai Biologia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.